Takeda Pharmaceutic-sp Adr (TAK) Held by Superinvestors

TAKEDA PHARMACEUTIC-SP ADR (TAK) is currently held by 3 superinvestors tracked by InsiderSet, with a combined reported market value of approximately $43.18M based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026.

Renaissance Technologies LLC is currently the largest disclosed institutional shareholder of TAK tracked by InsiderSet, reporting ownership valued at approximately $41.17M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $51.57M, representing an estimated gain of +25.27% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 100% of the total disclosed TAK value among the investors covered in this analysis. Major shareholders include Renaissance Technologies LLC, Sequoia Financial Advisors, Hancock Classic Value, and several other long-term asset managers with concentrated positions in TAKEDA PHARMACEUTIC-SP ADR (TAK).

This page ranks the largest institutional TAK shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Renaissance Technologies LLCJim Simons0.06%2,568,000$41,165,040$51,565,440+$10,400,400+25.27%
Sequoia Financial Advisors0.01%87,929$1,409,500$1,765,614+$356,114+25.27%
Hancock Classic ValueRichard Pzena0.00%37,820$606,253$759,426+$153,173+25.27%
Showing 3 of 3

Frequently asked questions about TAK

  • Who are the largest superinvestors holding TAK?

    The largest superinvestors holding TAK in the latest SEC Form 13F filings include Renaissance Technologies LLC, Sequoia Financial Advisors, and Hancock Classic Value. InsiderSet ranks these superinvestors by their latest reported TAK position.

  • What does the TAK superinvestors page include?

    This page tracks TAK positions reported by a curated group of notable institutional investors and fund managers through SEC Form 13F. TAKEDA PHARMACEUTIC-SP ADR (TAK) on this page reflects disclosed 13F holdings among those superinvestors, not every institutional shareholder of the stock.

  • How many superinvestors hold TAK?

    InsiderSet currently tracks 3 superinvestors reporting TAK holdings in the latest available 13F data. This is the curated set on this page, not the total number of institutions that own TAK.

  • How much TAK stock do superinvestors hold?

    Superinvestors tracked by InsiderSet disclosed approximately $43.18M in TAK holdings for Q2 2026. This figure is reported 13F value as of the filing period, not necessarily today's market value, and it covers the curated superinvestors on this page rather than every institutional filer.

  • When were TAK superinvestor holdings last updated?

    The latest TAK superinvestor holdings on InsiderSet are based on SEC Form 13F filings for the quarter ended June 30, 2026. Form 13F filings are generally reported after the quarter ends, so the holdings shown represent the latest publicly disclosed positions rather than real-time holdings.

  • Are superinvestor TAK holdings real-time?

    No. Form 13F data is not real-time. It represents positions reported by these superinvestors as of the end of the reporting quarter. A superinvestor may have changed its TAK position after the reporting date.

  • Are superinvestors buying or selling TAK?

    Buying and selling can be analyzed by comparing TAK positions across consecutive 13F reporting periods. InsiderSet's TAK Ownership Changes page shows institutions that increased, reduced, initiated, or exited positions based on reported 13F holdings. View TAK ownership changes.

  • How have superinvestor TAK holdings changed over time?

    InsiderSet tracks TAK holdings among these superinvestors across multiple 13F reporting periods, so holder counts, reported value, and reported shares can be compared over time.